Metastatic Lung Cancer : News

Healthline's Premium Tools

Symptom Search
Discover possible causes based on the symptoms you enter. It's fast, convenient and easy to use.
Pill Finder
Search by color, shape and markings. click here
Drug Interaction Checker
Check any 2 drugs for interactions. click here
Drug Compare
Compare any two drugs side by side. click here
Healthline Part D Plan Selector Medicare Part D
Medicare's drug plans are subsidized by the US federal government and offered through insurers.
Advertisement
Marketplace
... In general, lymph nodes become swollen when they are active either due to an infection , inflammation , or cancer . Infections Infections are the most common causes of swollen lymph nodes. Common infectious causes of swollen lymph nodes are viral, ...
Source:MedicineNet
Date:November 18, 2008
... as a molecular "safety switch," to prevent the spread of many cancers. Without the RNA switch keeping it in check, a cancer-promoting enzyme is freed to trigger the spread of prostate cancer. Researchers suspect the RNA may have similar effects on ...
Source:EMaxHealth
Date:November 18, 2008
... Squibb 's (NYSE: BMY ) Taxol and Sanofi-Aventis ' (NYSE: SNY ) Taxotere. It now stands at 42% of the second-line metastatic breast cancer market. While a 7% growth rate is decent for a drug that's been approved in the U.S. for nearly four years, it ...
Source:Fool.com
Date:November 17, 2008
These secondary tumors that originated in another organ are also known as "bone metastases." "Bone metastases are the most common cause of pain for cancer patients," notes Mark Hurwitz , MD, principal ...
Source:Rehab Management
Date:November 17, 2008
The new and powerful cancer drug sunitinib , which fights stomach tumors, can also create heart problems for some patients, a new study finds.
Source:CBC News
Date:November 17, 2008
The Ras-dependent ERK1/2 MAP kinase signaling pathway plays a central role in cell proliferation control and is frequently activated in human colorectal cancer.
Source:BMC Biotechnology
Date:November 17, 2008
Editor's note: This is the 15th installment of Assistant Metro Editor Ann DeMatteo's columns about breast cancer.
Source:New Haven Register
Date:November 16, 2008
... ONCY) announced today that a poster presentation authored by Dr. Anders Kolb of the Nemours Center for Childhood Cancer Research entitled "Systemic Administration of REOLYSIN Inhibits Growth of Human Sarcoma Xenografts Alone and in Combination with ...
Source:Med Ad News
Date:November 14, 2008
... The research site is in West Bloomfield, Mich. Please see http://www.centerwatch.com/patient/studies/cat51.html . Lung Cancer If you are at least 18, have inoperable stage III non-small cell lung cancer, and are stable after primary ...
Source:HON
Date:November 14, 2008
The poster presentation is authored by Dr. Anders Kolb of the Nemours Center for Childhood Cancer Research.
Source:M2.com
Date:November 14, 2008
... of 4 months over chemotherapy alone in patients with advanced adenocarcinoma, the most common form of non-small cell lung cancer (NSCLC). Avastin gives these patients a 45% better chance of survival compared to chemotherapy alone. The E4599 study ...
Source:Pharmaceutical Online
Date:November 14, 2008
... Einstein College of Medicine of Yeshiva University describe for the first time a method of viewing individual breast cancer cells for several days at a time. The study, by scientists in Einstein's Gruss Lipper Biophotonics Center, provides detail on ...
Source:MediLexicon
Date:November 13, 2008
> BASEL, SWITZERLAND, Nov. 13 /CNW/ - Roche announced today that an exploratory analysis of the pivotal phase III E4599 ...
Source:Canada NewsWire
Date:November 13, 2008
ImClone Systems Incorporated , a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that its disease-directed Phase 2 clinical trial of IMC-1121B in ...
Source:MediLexicon
Date:November 13, 2008
... Einstein College of Medicine of Yeshiva University describe for the first time a method of viewing individual breast cancer cells for several days at a time. The study, by scientists in Einstein's Gruss Lipper Biophotonics Center, provides detail on ...
Source:Medical News
Date:November 12, 2008
Advertisement
Back to Top